You are here:

Vaccine development

Vacinne development image

APHA Scientific can help you with each stage of your vaccine development. Our services range from generating data during the initial product development right through to batch release testing on the finished product.

We have a wealth of experience of in-vitro and in-vivo techniques and can work on a wide range of organisms including those which require high security containment.

The service includes:

  • Primary research
  • Antigen development
  • Testing for attenuation
  • Antibody and antigen detection
  • Extraneous agents testing
  • Efficacy and safety testing

Our microbiology unit can test starting materials for extraneous agents and purity including substances of animal origin, cell lines and bacterial and viral master seeds. It can also provide a comprehensive service for testing batches of vaccine for safety and efficacy in support of market authorisation, as well as, batch release testing of approved products.

Many of these services comply with Good Laboratory Practice, Good Manufacturing Practice and Good Clinical Practice (veterinary) as well as ISO17025 and ISO9001.

APHA Scientific also offers a wide range of animal disease challenge models for testing the efficacy of experimental vaccines to support market authorisation and batch testing. The challenge models include bacterial, viral and parasitological animal diseases.

Further information is available in the Vaccine Development brochure.

To discuss your requirements please contact our Customer Services Team

Tel:  +44 (0)3000 600001

Page last modified: 25 August, 2022